Mohammed Kashani-Sabet

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

Journal of translational medicine

Cells

Journal of personalized medicine

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, Juifang Fan, Robyn Jones, Anima Sharma, Mehdi Nosrati, Pierre-Yves Desprez, Nathan Salomonis, Yihui Shi, Altaf Dar, Mohammed Kashani-Sabet
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK. Journal of translational medicine 22 (1) (2024)
Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, Juifang Fan, Robyn Jones, Anima Sharma, Mehdi Nosrati, Pierre-Yves Desprez, Nathan Salomonis, Yihui Shi, Altaf Dar, Mohammed Kashani-Sabet
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK. Journal of translational medicine 22 (1) (2024)
Stanley P Leong, Mehdi Nosrati, Max C Wu, Donald M Torre, Ted F Bartley, Kevin B Kim, Christopher Soon, John Moretto, Mohammed Kashani-Sabet
Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery. Cancers 16 (15) (2024)
Stanley P Leong, Mehdi Nosrati, Max C Wu, Donald M Torre, Ted F Bartley, Kevin B Kim, Christopher Soon, John Moretto, Mohammed Kashani-Sabet
Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery. Cancers 16 (15) (2024)
Vladimir Bezrookove, Imran Khan, Anukana Bhattacharjee, Juifang Fan, Robyn Jones, Anima Sharma, Mehdi Nosrati, Pierre-Yves Desprez, Nathan Salomonis, Yihui Shi, Altaf Dar, Mohammed Kashani-Sabet
miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK. Journal of translational medicine 22 (1) (2024)
Maxim Sidorov, Pratiksha Dighe, Rinette W L Woo, Aida Rodriguez-Brotons, Michelle Chen, Ryan J Ice, Edith Vaquero, Damon Jian, Pierre-Yves Desprez, Mehdi Nosrati, Leah Galvez, Lewis Leng, Lawrence Dickinson, Mohammed Kashani-Sabet, Sean David McAllister, Liliana Soroceanu
Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment. Cells 12 (4) (2023)
Maxim Sidorov, Pratiksha Dighe, Rinette W L Woo, Aida Rodriguez-Brotons, Michelle Chen, Ryan J Ice, Edith Vaquero, Damon Jian, Pierre-Yves Desprez, Mehdi Nosrati, Leah Galvez, Lewis Leng, Lawrence Dickinson, Mohammed Kashani-Sabet, Sean David McAllister, Liliana Soroceanu
Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment. Cells 12 (4) (2023)
Maxim Sidorov, Pratiksha Dighe, Rinette W L Woo, Aida Rodriguez-Brotons, Michelle Chen, Ryan J Ice, Edith Vaquero, Damon Jian, Pierre-Yves Desprez, Mehdi Nosrati, Leah Galvez, Lewis Leng, Lawrence Dickinson, Mohammed Kashani-Sabet, Sean David McAllister, Liliana Soroceanu
Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment. Cells 12 (4) (2023)
Stephen H Chang, Ryan J Ice, Michelle Chen, Maxim Sidorov, Rinette W L Woo, Aida Rodriguez-Brotons, Damon Jian, Han Kyul Kim, Angela Kim, David E Stone, Ari Nazarian, Alyssia Oh, Gregory J Tranah, Mehdi Nosrati, David de Semir, Altaf A Dar, Pierre-Yves Desprez, Mohammed Kashani-Sabet, Liliana Soroceanu, Sean D McAllister
Pan-cancer pharmacogenomic analysis of patient-derived tumor cells utilizing clinically relevant drug exposures. Molecular cancer therapeutics (2023)
Michelle Chen, Damon Jian, Maxim Sidorov, Rinette W L Woo, Angela Kim, David E Stone, Ari Nazarian, Mehdi Nosrati, Ryan J Ice, David de Semir, Altaf A Dar, Roman Luštrik, Janez Kokošar, Luka Ausec, Michael C Rowbotham, Gregory J Tranah, Mohammed Kashani-Sabet, Liliana Soroceanu, Sean D McAllister, Pierre-Yves Desprez
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience. Journal of personalized medicine 12 (11) (2022)
Michelle Chen, Damon Jian, Maxim Sidorov, Rinette W L Woo, Angela Kim, David E Stone, Ari Nazarian, Mehdi Nosrati, Ryan J Ice, David de Semir, Altaf A Dar, Roman Luštrik, Janez Kokošar, Luka Ausec, Michael C Rowbotham, Gregory J Tranah, Mohammed Kashani-Sabet, Liliana Soroceanu, Sean D McAllister, Pierre-Yves Desprez
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience. Journal of personalized medicine 12 (11) (2022)
Steven L Morrison, Gang Han, Faith Elenwa, John T Vetto, Graham Fowler, Stanley P Leong, Mohammed Kashani-Sabet, Barbara A Pockaj, Heidi E Kosiorek, Jonathan S Zager, Vernon K Sondak, Jane L Messina, Nicola Mozzillo, Schlomo Schneebaum, Dale Han, null null
Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma? Cancer 128 (7) (2022)
Vladimir Bezrookove, Mohammed Kashani-Sabet
NCOA3, a new player in melanoma susceptibility and a therapeutic target. Cancer gene therapy 29 (5) (2022)
David de Semir, Vladimir Bezrookove, Mehdi Nosrati, Altaf A Dar, James R Miller, Stanley P Leong, Kevin B Kim, Wilson Liao, Liliana Soroceanu, Sean McAllister, Robert J Debs, Dirk Schadendorf, Sancy A Leachman, James E Cleaver, Mohammed Kashani-Sabet
Nuclear Receptor Coactivator NCOA3 Regulates UV Radiation-Induced DNA Damage and Melanoma Susceptibility. Cancer research 81 (11) (2021)
Mohammed Kashani-Sabet, James R Miller, Serigne N Lô, Mehdi Nosrati, Jonathan R Stretch, Kerwin F Shannon, Andrew J Spillane, Robyn P M Saw, James E Cleaver, Kevin B Kim, Stanley P Leong, John F Thompson, Richard A Scolyer
Reappraisal of the prognostic significance of mitotic rate supports its reincorporation into the melanoma staging system. Cancer 126 (21) (2020)
Sarah Ursu, Shahana Majid, Caroline Garger, David de Semir, Vladimir Bezrookove, Pierre-Yves Desprez, Sean McAllister, Liliana Soroceanu, Mehdi Nosrati, Kidist Yimam, Assad Hassoun, Robert Osorio, Mohammed Kashani-Sabet, Altaf A Dar
Novel tumor suppressor role of miRNA-876 in cholangiocarcinoma. Oncogenesis 8 (8) (2019)

Mohammed Kashani-Sabet.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammed Kashani-Sabet